Abstract
Aims Several studies indicated that short-term administration of α-glucosidase inhibitors (α-GIs) significantly reduces postprandial glucose-dependent insulinotropic polypeptide (GIP) secretion. However, little is known about the long-term effect. We investigated the effects of long-term miglitol administration on GIP secretion and body weight in patients with type 2 diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.